Abstract

Introduction: Familial breast cancer has significant implications for both patients and health care systems in terms of quality of life and costs. Despite NICE recommendations, there is a lack of a uniform system across UK for identification and referral. In many regions, primary care is responsible for this referral pathway. In symptomatic clinics, appropriate identification of at risk individuals can be effectively performed through an accurate family history. We assessed if patients with significant family history risk were being recognised and subsequently referred to a specialist genetic clinic.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.